Inspire Medical Systems Files 8-K
Ticker: INSP · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Aug 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $200.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, sec
TL;DR
Inspire Medical Systems filed an 8-K on 8/11/25. Check for updates.
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on August 11, 2025, reporting other events and financial statements/exhibits. The filing does not detail specific transactions or financial figures but serves as a notification of these items being filed.
Why It Matters
This filing indicates that Inspire Medical Systems has submitted important updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain specific negative or positive news that would immediately impact risk.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — Registrant
- August 11, 2025 (date) — Date of report
- 5500 Wayzata Blvd. , Suite 1600 Golden Valley , Minnesota 55416 (address) — Principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as the items being reported, but the specific details of these events are not provided in the header information.
When was this 8-K report filed?
The report was filed on August 11, 2025.
What is the principal business address of Inspire Medical Systems, Inc.?
The principal executive offices are located at 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.
What is the Commission File Number for Inspire Medical Systems, Inc.?
The Commission File Number is 001-38468.
What is the SIC code for Inspire Medical Systems, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 465 words · 2 min read · ~2 pages · Grade level 8.8 · Accepted 2025-08-11 16:16:24
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
- $200.0 million — has authorized the repurchase of up to $200.0 million of the Company's outstanding shares of
Filing Documents
- insp-20250811.htm (8-K) — 25KB
- a2025-8x11xxinspxxsharer.htm (EX-99.1) — 10KB
- a2025-8x11xxinspxxsharer001.jpg (GRAPHIC) — 224KB
- a2025-8x11xxinspxxsharer002.jpg (GRAPHIC) — 290KB
- a2025-8x11xxinspxxsharer003.jpg (GRAPHIC) — 204KB
- 0001609550-25-000035.txt ( ) — 1144KB
- insp-20250811.xsd (EX-101.SCH) — 2KB
- insp-20250811_lab.xml (EX-101.LAB) — 22KB
- insp-20250811_pre.xml (EX-101.PRE) — 13KB
- insp-20250811_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On August 11, 2025, Inspire Medical Systems, Inc. (the "Company") issued a press release announcing that its Board of Directors has authorized the repurchase of up to $200.0 million of the Company's outstanding shares of common stock. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Inspire Medical Systems, Inc. press release dated August 11, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: August 11, 2025 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel 3